These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 39143142)
1. Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis. Lu Y; Jiang J; He Z; Bao Z; Chen X; Cheng J Sci Rep; 2024 Aug; 14(1):18923. PubMed ID: 39143142 [TBL] [Abstract][Full Text] [Related]
2. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7. Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742 [TBL] [Abstract][Full Text] [Related]
3. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells. Lu M; Ding N; Zhuang S; Li Y Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor. Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626 [TBL] [Abstract][Full Text] [Related]
5. The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities. Manning BJ; Yusufzai T J Biol Chem; 2017 Jul; 292(28):11927-11936. PubMed ID: 28533432 [TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of genes encoding ATP-dependent chromatin remodellers identifies CHD7 as a potential target for colorectal cancer therapy. Zhang X; Zhou Y; Shi Z; Liu Z; Chen H; Wang X; Cheng Y; Xi L; Li X; Zhang C; Bao L; Xuan C Clin Transl Med; 2022 Jul; 12(7):e953. PubMed ID: 35789070 [TBL] [Abstract][Full Text] [Related]
8. Gene expression regulation by the Chromodomain helicase DNA-binding protein 9 (CHD9) chromatin remodeler is dispensable for murine development. Alendar A; Lambooij JP; Bhaskaran R; Lancini C; Song JY; van Vugt H; Snoek M; Berns A PLoS One; 2020; 15(5):e0233394. PubMed ID: 32453735 [TBL] [Abstract][Full Text] [Related]
9. MiR-130b-3p promotes colorectal cancer progression by targeting CHD9. Song D; Zhang Q; Zhang H; Zhan L; Sun X Cell Cycle; 2022; 21(6):585-601. PubMed ID: 35100082 [TBL] [Abstract][Full Text] [Related]
10. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Schnetz MP; Bartels CF; Shastri K; Balasubramanian D; Zentner GE; Balaji R; Zhang X; Song L; Wang Z; Laframboise T; Crawford GE; Scacheri PC Genome Res; 2009 Apr; 19(4):590-601. PubMed ID: 19251738 [TBL] [Abstract][Full Text] [Related]
11. Genetic and expressional alterations of CHD genes in gastric and colorectal cancers. Kim MS; Chung NG; Kang MR; Yoo NJ; Lee SH Histopathology; 2011 Apr; 58(5):660-8. PubMed ID: 21447119 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of circ-SFMBT2 blocks the development of gastric cancer by targeting the miR-885-3p/CHD7 pathway. He Y; Zhang Z; Wang Z; Jiao Y; Kang Q; Li J Anticancer Drugs; 2022 Jan; 33(1):e247-e259. PubMed ID: 34387601 [TBL] [Abstract][Full Text] [Related]
13. Chromatin gatekeeper and modifier CHD proteins in development, and in autism and other neurological disorders. Muhammad T; Pastore SF; Good K; AusiĆ³ J; Vincent JB Psychiatr Genet; 2023 Dec; 33(6):213-232. PubMed ID: 37851134 [TBL] [Abstract][Full Text] [Related]
15. A Novel N-terminal Region to Chromodomain in CHD7 is Required for the Efficient Remodeling Activity. Lee E; Kang C; Purhonen P; Hebert H; Bouazoune K; Hohng S; Song JJ J Mol Biol; 2021 Sep; 433(18):167114. PubMed ID: 34161779 [TBL] [Abstract][Full Text] [Related]
16. ATP-Dependent Chromatin Remodeler CHD9 Controls the Proliferation of Embryonic Stem Cells in a Cell Culture Condition-Dependent Manner. Yoo H; La H; Lee EJ; Choi HJ; Oh J; Thang NX; Hong K Biology (Basel); 2020 Nov; 9(12):. PubMed ID: 33261017 [TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in Colorectal Cancer: Integrating Bioinformatics Analysis with Experimental Confirmation. Liu YM; Yang TC; Fang XC; Yang LJ; Shi LW; Wang HQ; Dou TT; Shu L; Chen TL; Hu J; Yu XM; Li XF Curr Med Sci; 2024 Jun; 44(3):529-544. PubMed ID: 38809379 [TBL] [Abstract][Full Text] [Related]
18. Mutation update on the CHD7 gene involved in CHARGE syndrome. Janssen N; Bergman JE; Swertz MA; Tranebjaerg L; Lodahl M; Schoots J; Hofstra RM; van Ravenswaaij-Arts CM; Hoefsloot LH Hum Mutat; 2012 Aug; 33(8):1149-60. PubMed ID: 22461308 [TBL] [Abstract][Full Text] [Related]
19. The panoramic picture of pepsinogen gene family with pan-cancer. Shen S; Li H; Liu J; Sun L; Yuan Y Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of fbxl10/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome. Balow SA; Pierce LX; Zentner GE; Conrad PA; Davis S; Sabaawy HE; McDermott BM; Scacheri PC Dev Biol; 2013 Oct; 382(1):57-69. PubMed ID: 23920116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]